Teladoc Health, Inc. announced on June 28, 2024, the company terminated without cause the employment of Laizer Kornwasser, President, Enterprise Growth and Global Markets, in connection with a change in the company's executive reporting structure, effective July 1, 2024. Mr. Kornwasser will remain employed with the company as Advisor to the Chief Executive Officer until August 2, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.26 USD | -1.38% |
|
0.00% | -57.03% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.03% | 1.57B | |
+156.63% | 4.91B | |
-14.96% | 367M | |
+8.04% | 353M | |
-75.00% | 111M | |
-35.25% | 82.43M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health, Inc. Announces Termination of Laizer Kornwasser as President, Enterprise Growth and Global Markets